Form 4 for SLDB Solid Biosciences Inc.
Accepted 2024-10-22 00:00:00 ET · period of report 2024-10-18 · accession 0000950170-24-116246 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-22 | 2024-10-18 | SLDB | Brooks Gabriel | Chief Medical Off | M - OptEx | — | +9,750 | 13.9K | +235% | — |
| D | 2024-10-22 | 2024-10-21 | SLDB | Brooks Gabriel | Chief Medical Off | S - Sale+OE | $6.50 | -2,923 | 11.0K | -21% | -$19.0K |
| D | 2024-10-22 | 2024-10-18 | SLDB | Brooks Gabriel | Chief Medical Off | M - OptEx | $0.00 | -9,750 | 29.2K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-18 | M | A | 9,750 | — | 13,902 | D | — | — | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F2) Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024. |
| 2 | Common | Common Stock | 2024-10-21 | S | D | 2,923 | $6.50 | 10,979 | D | — | — | (F3) This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. |
| 3 | Derivative | Restricted Stock Units | 2024-10-18 | M | D | 9,750 | $0.00 | 29,250 | D | — · — to — | 9,750 Common Stock | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F4) The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. |